MMP9 and androgen insensitivity syndrome: Thus, in AIS patients with poorly controlled diabetes, their increased risk of symptomatic hemorrhagic transformation might be explained in part by increased MMP-9 activity, though further studies are needed to confirm this hypothesis and understand its relationships with the time course and mechanisms of effect.